490 reports of this reaction
2.9% of all GLYCERIN reports
#4 most reported adverse reaction
CONSTIPATION is the #4 most commonly reported adverse reaction for GLYCERIN, manufactured by Geri-Care Pharmaceuticals, Corp. There are 490 FDA adverse event reports linking GLYCERIN to CONSTIPATION. This represents approximately 2.9% of all 16,949 adverse event reports for this drug.
Patients taking GLYCERIN who experience constipation should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CONSTIPATION is a less commonly reported adverse event for GLYCERIN, but still significant enough to appear in the safety profile.
In addition to constipation, the following adverse reactions have been reported for GLYCERIN:
The following drugs have also been linked to constipation in FDA adverse event reports:
CONSTIPATION has been reported as an adverse event in 490 FDA reports for GLYCERIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
CONSTIPATION accounts for approximately 2.9% of all adverse event reports for GLYCERIN, making it a notable side effect.
If you experience constipation while taking GLYCERIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.